Serum sphingomyelin has potential to reflect hepatic injury in chronic hepatitis B virus infection

Su-Jun Zheng1, Feng Qu2, Jun-Feng Li3

  • 1Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing, China.

Insights

Serum sphingolipids are linked to liver injury in chronic hepatitis B virus (HBV) infection. Specific sphingomyelin (SM) compounds, like SM(d18:1/24:0), may serve as biomarkers for hepatic injury and cirrhosis.

Area of Science:

  • Biochemistry
  • Hepatology
  • Biomarker Discovery

Background:

  • Chronic hepatitis B virus (HBV) infection is a significant global health concern.
  • Hepatic injury and cirrhosis are serious complications of chronic HBV infection.
  • Understanding the molecular mechanisms underlying liver damage in HBV is crucial for developing new diagnostic tools.

Purpose of the Study:

  • To investigate the association between serum sphingolipid profiles and the severity of hepatic injury in patients with chronic HBV infection.
  • To identify potential serum biomarkers for liver damage and cirrhosis in the context of chronic HBV.

Main Methods:

  • Serum samples from healthy individuals and patients with chronic HBV infection (including chronic hepatitis B and HBV-related cirrhosis) were analyzed.
  • High-performance liquid chromatography coupled to tandem mass spectrometry (HPLC-MS/MS) was employed to quantify serum sphingolipids.
  • Liver biopsy data and clinical indicators, such as the Model for End-Stage Liver Disease (MELD) score, were correlated with sphingolipid levels.

Main Results:

  • Eighteen out of twenty-four detected serum sphingolipids showed significant differences between healthy controls and chronic HBV-infected individuals.
  • Fourteen sphingolipids were significantly different between chronic hepatitis B and HBV-related cirrhosis groups.
  • Sphingomyelin (SM) compound SM(d18:1/24:0) demonstrated a negative correlation with MELD score and was associated with inflammation grades in liver biopsies.

Conclusions:

  • Serum sphingolipids are closely related to hepatic injury in chronic HBV infection.
  • SM(d18:1/24:0) shows potential as a non-invasive serum biomarker for assessing liver damage and disease progression in chronic HBV patients.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
877
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
3
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
3